New Zealand consumers’ perceptions of private insurance for pharmaceuticals

Rajan Ragupathy, Zaheer ud Din Babar, Wasif Mirza, Mitali Daiya, Himesh Chandra, Ali Yousif, Maninder Girn

Research output: Contribution to journalArticle

Abstract

Private insurance plays a minor role in paying for pharmaceuticals in New Zealand, despite controversy about access through the public health system. The present study examines New Zealand consumers’ perceptions of private insurance for pharmaceuticals. A self-administered questionnaire was completed by 433 consumers at thirty pharmacies. The questionnaire included 18 questions on demographics, insurance status, perceptions of private insurance for pharmaceuticals and confidence in the public health system. Forty six percent of respondents had private health insurance. Respondents were more likely to have private health insurance as household income increased, and confidence in the public health system decreased. (Over two thirds of respondents were either confident or very confident in the public health system). Nineteen percent had private health insurance for pharmaceuticals, and the likelihood was not affected by household income or confidence in the public health system. Sixty one percent believed private insurance for pharmaceuticals would increase availability and affordability of pharmaceuticals. However, just over half were willing to pay for private insurance for pharmaceuticals. Of these, over two thirds were only willing to pay $20 per year or less. New Zealand pharmacy consumers’ willingness to pay for private insurance for pharmaceuticals is very low.

Original languageEnglish
Article number587
Number of pages6
JournalSpringerPlus
Volume3
Issue number1
DOIs
Publication statusPublished - 8 Oct 2014
Externally publishedYes

Fingerprint

Consumer perceptions
Pharmaceuticals
Insurance
New Zealand
Public health
Confidence
Private health insurance
Household income
Questionnaire
Affordability
Willingness-to-pay
Demographics

Cite this

Ragupathy, R., Babar, Z. U. D., Mirza, W., Daiya, M., Chandra, H., Yousif, A., & Girn, M. (2014). New Zealand consumers’ perceptions of private insurance for pharmaceuticals. SpringerPlus, 3(1), [587]. https://doi.org/10.1186/2193-1801-3-587
Ragupathy, Rajan ; Babar, Zaheer ud Din ; Mirza, Wasif ; Daiya, Mitali ; Chandra, Himesh ; Yousif, Ali ; Girn, Maninder. / New Zealand consumers’ perceptions of private insurance for pharmaceuticals. In: SpringerPlus. 2014 ; Vol. 3, No. 1.
@article{1e4d3ce93c034bb4b0a046bffbd81096,
title = "New Zealand consumers’ perceptions of private insurance for pharmaceuticals",
abstract = "Private insurance plays a minor role in paying for pharmaceuticals in New Zealand, despite controversy about access through the public health system. The present study examines New Zealand consumers’ perceptions of private insurance for pharmaceuticals. A self-administered questionnaire was completed by 433 consumers at thirty pharmacies. The questionnaire included 18 questions on demographics, insurance status, perceptions of private insurance for pharmaceuticals and confidence in the public health system. Forty six percent of respondents had private health insurance. Respondents were more likely to have private health insurance as household income increased, and confidence in the public health system decreased. (Over two thirds of respondents were either confident or very confident in the public health system). Nineteen percent had private health insurance for pharmaceuticals, and the likelihood was not affected by household income or confidence in the public health system. Sixty one percent believed private insurance for pharmaceuticals would increase availability and affordability of pharmaceuticals. However, just over half were willing to pay for private insurance for pharmaceuticals. Of these, over two thirds were only willing to pay $20 per year or less. New Zealand pharmacy consumers’ willingness to pay for private insurance for pharmaceuticals is very low.",
keywords = "private insurance, private health insurance, public health system, participant information sheet, pharmaceutical cost",
author = "Rajan Ragupathy and Babar, {Zaheer ud Din} and Wasif Mirza and Mitali Daiya and Himesh Chandra and Ali Yousif and Maninder Girn",
year = "2014",
month = "10",
day = "8",
doi = "10.1186/2193-1801-3-587",
language = "English",
volume = "3",
journal = "SpringerPlus",
issn = "2193-1801",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "1",

}

Ragupathy, R, Babar, ZUD, Mirza, W, Daiya, M, Chandra, H, Yousif, A & Girn, M 2014, 'New Zealand consumers’ perceptions of private insurance for pharmaceuticals', SpringerPlus, vol. 3, no. 1, 587. https://doi.org/10.1186/2193-1801-3-587

New Zealand consumers’ perceptions of private insurance for pharmaceuticals. / Ragupathy, Rajan; Babar, Zaheer ud Din; Mirza, Wasif; Daiya, Mitali; Chandra, Himesh; Yousif, Ali; Girn, Maninder.

In: SpringerPlus, Vol. 3, No. 1, 587, 08.10.2014.

Research output: Contribution to journalArticle

TY - JOUR

T1 - New Zealand consumers’ perceptions of private insurance for pharmaceuticals

AU - Ragupathy, Rajan

AU - Babar, Zaheer ud Din

AU - Mirza, Wasif

AU - Daiya, Mitali

AU - Chandra, Himesh

AU - Yousif, Ali

AU - Girn, Maninder

PY - 2014/10/8

Y1 - 2014/10/8

N2 - Private insurance plays a minor role in paying for pharmaceuticals in New Zealand, despite controversy about access through the public health system. The present study examines New Zealand consumers’ perceptions of private insurance for pharmaceuticals. A self-administered questionnaire was completed by 433 consumers at thirty pharmacies. The questionnaire included 18 questions on demographics, insurance status, perceptions of private insurance for pharmaceuticals and confidence in the public health system. Forty six percent of respondents had private health insurance. Respondents were more likely to have private health insurance as household income increased, and confidence in the public health system decreased. (Over two thirds of respondents were either confident or very confident in the public health system). Nineteen percent had private health insurance for pharmaceuticals, and the likelihood was not affected by household income or confidence in the public health system. Sixty one percent believed private insurance for pharmaceuticals would increase availability and affordability of pharmaceuticals. However, just over half were willing to pay for private insurance for pharmaceuticals. Of these, over two thirds were only willing to pay $20 per year or less. New Zealand pharmacy consumers’ willingness to pay for private insurance for pharmaceuticals is very low.

AB - Private insurance plays a minor role in paying for pharmaceuticals in New Zealand, despite controversy about access through the public health system. The present study examines New Zealand consumers’ perceptions of private insurance for pharmaceuticals. A self-administered questionnaire was completed by 433 consumers at thirty pharmacies. The questionnaire included 18 questions on demographics, insurance status, perceptions of private insurance for pharmaceuticals and confidence in the public health system. Forty six percent of respondents had private health insurance. Respondents were more likely to have private health insurance as household income increased, and confidence in the public health system decreased. (Over two thirds of respondents were either confident or very confident in the public health system). Nineteen percent had private health insurance for pharmaceuticals, and the likelihood was not affected by household income or confidence in the public health system. Sixty one percent believed private insurance for pharmaceuticals would increase availability and affordability of pharmaceuticals. However, just over half were willing to pay for private insurance for pharmaceuticals. Of these, over two thirds were only willing to pay $20 per year or less. New Zealand pharmacy consumers’ willingness to pay for private insurance for pharmaceuticals is very low.

KW - private insurance

KW - private health insurance

KW - public health system

KW - participant information sheet

KW - pharmaceutical cost

UR - http://www.scopus.com/inward/record.url?scp=84933049277&partnerID=8YFLogxK

U2 - 10.1186/2193-1801-3-587

DO - 10.1186/2193-1801-3-587

M3 - Article

VL - 3

JO - SpringerPlus

JF - SpringerPlus

SN - 2193-1801

IS - 1

M1 - 587

ER -